These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15097299)

  • 1. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.
    Mahajan AP; Hogan JW; Snyder B; Kumarasamy N; Mehta K; Solomon S; Carpenter CC; Mayer KH; Flanigan TP
    J Acquir Immune Defic Syndr; 2004 May; 36(1):567-75. PubMed ID: 15097299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.
    Wang Y; Liang S; Yu E; Guo J; Li Z; Wang Z; Du Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):712. PubMed ID: 22038367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
    Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
    Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
    Spacek LA; Griswold M; Quinn TC; Moore RD
    AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
    Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
    Gitura B; Joshi MD; Lule GN; Anzala O
    East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource-limited setting in India.
    Srirangaraj S; Venkatesha D
    Indian J Med Res; 2012 Jun; 135(6):895-900. PubMed ID: 22825609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.
    Cheung C; Shuter J
    Int J STD AIDS; 2010 Jun; 21(6):406-9. PubMed ID: 20606220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.
    Anastos K; Shi Q; French AL; Levine A; Greenblatt RM; Williams C; DeHovitz J; Delapenha R; Hoover DR
    J Acquir Immune Defic Syndr; 2004 Apr; 35(4):383-92. PubMed ID: 15097155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy.
    Sreenivasan S; Dasegowda V
    J Glob Infect Dis; 2011 Jul; 3(3):265-8. PubMed ID: 21887059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
    Obirikorang C; Quaye L; Acheampong I
    BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of total lymphocyte count as a surrogate for absolute CD4 count in the adult Indian HIV population: A prospective study.
    Karanth SS; Rau NR; Gupta A; Kamath A; Shanbhogue V; Pruthvi BC
    Avicenna J Med; 2014 Jan; 4(1):1-4. PubMed ID: 24678463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
    Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating total lymphocyte count as a surrogate marker for CD4 cell count in the management of HIV-infected patients in resource-limited settings: a study from China.
    Chen J; Li W; Huang X; Guo C; Zou R; Yang Q; Zhang H; Zhang T; Chen H; Wu H
    PLoS One; 2013; 8(7):e69704. PubMed ID: 23874985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings.
    Badri M; Wood R
    AIDS; 2003 Mar; 17(4):541-5. PubMed ID: 12598774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
    Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
    BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use.
    Mwamburi DM; Ghosh M; Fauntleroy J; Gorbach SL; Wanke CA
    Am J Trop Med Hyg; 2005 Jul; 73(1):58-62. PubMed ID: 16014833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
    Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
    Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.